Shanghai Newsummit Biopharma, HandInScan Sign Agreement to Commercialize IC Technology in China

Shanghai Newsummit Biopharma and HandInScan announce that they have signed an agreement to introduce the HandInScan technology in China through validation with leading hospitals and key opinion leaders. The signing took place at the Wenzhou Biomedical Innovation Center Healthcare Forum held during the week of the China G20 Summit in the presence of Dai Tao, deputy director of the Development Center for Medical Science & Technology of the National Health & Family Planning Commission, and Zhang Geng, mayor of Wenzhou.

The HandInScan Technology is the only quality-assured system focusing on hand disinfection quality control that can objectively determine hand hygiene effectiveness. The system is designed to teach and verify if protocols are followed properly.

Dr. Jun Ren, CEO of Shanghai Newsummit Biopharma, said, "We are proud to form an alliance with HandinScan, since their technology can deliver an effective solution to healthcare organizations. The technology is now utilized in over 20 countries worldwide, and healthcare organizations implementing the HandInScan technology are seeing the effect of patient safety and provider benefits that the system can deliver. We believe the healthcare system in China and Chinese patients can also benefit from this innovation."

Peter Rona, CEO of HandinScan added, "We believe that Newsummit is the right organization to bring healthcare related innovation into China. This partnership is an important milestone in our commercial strategy. We look forward to working with Newsummit in bringing the benefits of the systems to Chinese hospitals."

Source: HandInScan